wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57139434-0A86CACE-CD63-4F88-9C19-C9FF51663D4F
Q57139434-0A86CACE-CD63-4F88-9C19-C9FF51663D4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57139434-0A86CACE-CD63-4F88-9C19-C9FF51663D4F
Angiogenesis inhibitors in the treatment of prostate cancer
P2860
Q57139434-0A86CACE-CD63-4F88-9C19-C9FF51663D4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57139434-0A86CACE-CD63-4F88-9C19-C9FF51663D4F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd9820bc38d433e2744f93c71823695ee63b6b89
P2860
Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.